Site4Drug: Predicting Drug-Binding Target Sites with an AI Agent
Selecting where to intervene on a protein (i.e., choosing a targetable site) is often a more ambiguous and failure-prone bottleneck than selecting what binds, especially for membrane proteins where accessibility, topology, and post-translational modifications (PTMs) constrain actionable regions. We present Site4Drug, a modality-aware site-finding agent that outputs a ranked list of targetable regions with explicit constraints, evidence summaries, risk flags, and a traceable decision log. Rather than requiring users to specify the drug modality upfront, Site4Drug can recommend a binding modality (e.g., antibody/peptide-like vs small-molecule) from the same evidence used for site discovery, including topology, hydropathy, PTM propensity, disulfides, domain context, and sequence. Importantly, this evidence is applied consistently across modalities, including small-molecule pocket discovery, to avoid selecting chemically plausible but biologically occluded sites.
Code (0)
등록된 구현이 없습니다.
Similar Papers 제목 키워드 기반
FusionDTI: Fine-grained Binding Discovery with Token-level Fusion for Drug-Target Interaction
Predicting drug-target interaction (DTI) is critical in the drug discovery process. Despite remarkable advances in recent DTI models through the integration of representations from diverse drug and target encoders, such …
Drug DesignDrug DiscoveryDrug-target affinity prediction method based on consistent expression of heterogeneous data
The first step in drug discovery is finding drug molecule moieties with medicinal activity against specific targets. Therefore, it is crucial to investigate the interaction between drug-target proteins and small chemical…
Drug DiscoveryResDTA: Predicting Drug-Target Binding Affinity Using Residual Skip Connections
The discovery of novel drug target (DT) interactions is an important step in the drug development process. The majority of computer techniques for predicting DT interactions have focused on binary classification, with th…
Binary ClassificationDeep LearningAI-Bind: Improving Binding Predictions for Novel Protein Targets and Ligands
Identifying novel drug-target interactions (DTI) is a critical and rate limiting step in drug discovery. While deep learning models have been proposed to accelerate the identification process, we show that state-of-the-a…
Drug DiscoveryUnsupervised Pre-trainingAttentionSiteDTI: an interpretable graph-based model for drug-target interaction prediction using NLP sentence-level relation classification
In this study, we introduce an interpretable graph-based deep learning prediction model, AttentionSiteDTI, which utilizes protein binding sites along with a self-attention mechanism to address the problem of drug–target …
Drug DiscoveryRelation ClassificationSentenceSentence Classification